Updates
-
-
SPMS and the Continuum of Acceptance
Some days are hard, while others are still harder. Then there are days that bring you to your knees. I am ... Read more -
#ECTRIMS2018 — High Vitamin D Levels, Smoking Predict Opposite Effects on Cognition in CIS Patients, Study Suggests
High vitamin D levels predict better cognitive function, while smoking is associated with worse long-term cognitive disability in patients with ... Read more -
#ECTRIMS2018 – GNbAC1 Shows Consistent Neuroprotection in RRMS Patients, Phase 2b Study Reports
Treating relapsing-remitting multiple sclerosis (RRMS) patients with GeNeuro’s investigational compound GNbAC1 lessened brain atrophy and lesion load and suggested myelin ... Read more -
#ECTRIMS2018 – Role of Brain Atrophy in MS Progression Poorly Understood by Patients, MSAA Survey Finds
Although brain atrophy — the loss of brain volume — is an increasingly important measure in multiple sclerosis trials and treatment ... Read more -
#ECTRIMS2018 – Serum Neurofilament Light Show Promise as Biomarker, But Not There Yet, Neurologists Say
Despite its lack of specificity to multiple sclerosis (MS) in particular, monitoring patients with a blood biomarker — serum neurofilament light ... Read more
-
-
#ECTRIMS2018 – Blood Level of Neurofilament Light Chain May Predict Brain Atrophy in Progressive MS, Study Suggests
Measuring the blood level of neurofilament light chain (NfL) may predict ... -
#ECTRIMS2018 – Stem Cell Transplant Effectively Lessens Disability in Patients with Aggressive MS, Study Finds
Treatment with autologous hematopoietic stem cell transplant (aHSCT) led to a ... -
#ECTRIMS2018 – Evobrutinib Seen to Lower Active Brain Lesions in Phase 2 Trial
Merck KGaA announced that evobrutinib, its oral candidate for relapsing multiple ... -
-
#ECTRIMS2018 – Shifting from Gilenya to Lemtrada Doesn’t Increase Risk of MS Reactivation, Study Says
Shifting from treatment with Gilenya (fingolimod) to Lemtrada (alemtuzumab), and doing ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device ... Read more